Robin Murray

Last updated

Sir

Robin Murray
Robin Murray at the Mental Health conference in Hanover, April 2013 - IMAG5320-cropped.png
Born
Robin MacGregor Murray

(1944-01-31) 31 January 1944 (age 80)
Glasgow, Scotland
CitizenshipBritish
Alma mater University of Glasgow
Scientific career
FieldsPsychiatry, Schizophrenia, Bipolar Disorder, Psychosis
Institutions Institute of Psychiatry
King's College London

Sir Robin MacGregor Murray FRS (born 31 January 1944 in Glasgow) is a British psychiatrist, Professor of Psychiatric Research at the Institute of Psychiatry, King's College London. [1] He has treated patients with schizophrenia and bipolar illness referred to the National Psychosis Unit of the South London and Maudsley NHS Trust [2] because they fail to respond to treatment, or cannot get appropriate treatment, locally; he sees patients privately if they are unable to obtain an NHS referral.

Contents

Education and career

Robin Murray trained in medicine at the University of Glasgow. After qualifying, he researched chronic renal failure induced by the massive abuse of a local headache powder, Askit Powders. Then he started training in psychiatry at the Maudsley Hospital in London and has remained there ever since apart from one year at the National Institute of Mental Health in the USA. He has been Dean of the Institute of Psychiatry, King's College London, and Professor of Psychiatry there, but now focuses on research into and care of people with psychotic illness. In 1987 he and Shon Lewis were among the first to suggest that schizophrenia might in part be a neurodevelopmental disorder. [ citation needed ]

Professor Murray is part of The Psychosis Research Group at the Institute of Psychiatry, perhaps the largest (by number of papers produced per annum) in the world. It uses a range of methods to improve understanding and treatment of psychotic illnesses, particularly schizophrenia. Murray is ranked as one of the most influential researchers in psychiatry by Thomson Reuters' Science Watch [3] and 3rd in schizophrenia research. [4]

In 1994, he was the president of the European Association of Psychiatrists; now the European Psychiatric Association. He is a Fellow of the Royal Society (elected 2010) and also a Fellow of the Royal College of Psychiatrists. [1] Murray is co-editor-in-chief of Psychological Medicine . [5] He was Chairman of the Schizophrenia Commission which, over 2011 and 2012, reviewed in detail the care of people with psychosis in England, and concluded people with this illness were neglected, often poorly treated and subject to discrimination. The Commission made numerous recommendations for improvement.[ citation needed ]

Robin Murray and colleagues were among the first to demonstrate that prolonged heavy abuse of cannabis can contribute to the onset of psychosis, and that starting early before 15 years and using high potency cannabis (e.g. skunk) particularly increase the risk. Currently, they are researching why some people are especially vulnerable to this drug while most develop no problems. In 2009 Murray had a public disagreement with David Nutt in the pages of The Guardian about the dangers of cannabis in triggering psychosis. [6]

Murray previously wrote that while the risk increase is "about five-fold [...] for the heaviest users", the issue has become a political football. [4] Murray has commented repeatedly on these issues in BBC articles and programs, [7] [8] [9] including in a Panorama documentary on BBC One. [10] [11]

Knighthood

Murray was knighted in the 2011 New Year Honours for his services to medicine. [12]

See also

Related Research Articles

Psychosis is a condition of the mind that results in difficulties determining what is real and what is not real. Symptoms may include delusions and hallucinations, among other features. Additional symptoms are incoherent speech and behavior that is inappropriate for a given situation. There may also be sleep problems, social withdrawal, lack of motivation, and difficulties carrying out daily activities. Psychosis can have serious adverse outcomes.

Schizoaffective disorder is a mental disorder characterized by abnormal thought processes and an unstable mood. This diagnosis requires symptoms of both schizophrenia and a mood disorder: either bipolar disorder or depression. The main criterion is the presence of psychotic symptoms for at least two weeks without any mood symptoms. Schizoaffective disorder can often be misdiagnosed when the correct diagnosis may be psychotic depression, bipolar I disorder, schizophreniform disorder, or schizophrenia. This is a problem as treatment and prognosis differ greatly for most of these diagnoses.

Richard Bentall is a Professor of Clinical Psychology at the University of Sheffield in the UK.

<span class="mw-page-title-main">Raj Persaud</span>

Rajendra 'Raj' Persaud FRCPsych is an English consultant psychiatrist, broadcaster and author of books about psychiatry. He is known for raising public awareness of psychiatric and mental health issues in the general media, has published five books and received numerous awards.

<span class="mw-page-title-main">Institute of Psychiatry, Psychology and Neuroscience</span> Research institution in London, England

The Institute of Psychiatry, Psychology & Neuroscience (IoPPN) is a leading centre for mental health and neuroscience research, education and training in Europe. It is dedicated to understanding, preventing and treating mental illness, neurological conditions, and other conditions that affect the brain. The IoPPN is a faculty of King's College London, England, and was previously known as the Institute of Psychiatry (IoP).

Theodore Lidz was an American psychiatrist best known for his articles and books on the causes of schizophrenia and on psychotherapy with patients with schizophrenia. An advocate of research into environmental causes of mental illness, Lidz was a notable critic of what he saw as a disproportionate focus on biological psychiatry. Lidz was a Sterling Professor of Psychiatry at Yale University. In his lifetime, he did a great amount of research on interpersonal causes of schizophrenia.

Peter McGuffin was a Northern Irish psychiatrist and geneticist from Belfast.

Eliot Trevor Oakeshott Slater MD was a British psychiatrist who was a pioneer in the field of the genetics of mental disorders. He held senior posts at the National Hospital for Nervous Diseases, Queen Square, London, and the Institute of Psychiatry at the Maudsley Hospital. He was the author of some 150 scientific papers and the co-author of several books on psychiatric topics, notably on disputed 'physical methods'. From the mid-50s to his death, he co-edited Clinical Psychiatry, the leading textbook for psychiatric trainees.

Loren Richard Mosher was an American psychiatrist, clinical professor of psychiatry, expert on schizophrenia and the chief of the Center for Studies of Schizophrenia in the National Institute of Mental Health (1968–1980). Mosher spent his professional career advocating for humane and effective treatment for people diagnosed as having schizophrenia and was instrumental in developing an innovative, residential, home-like, non-hospital, non-drug treatment model for newly identified acutely psychotic persons.

Pierre Flor-Henry is a Canadian psychiatrist, researcher, lecturer, and professor. His most important initial contribution was the demonstration in the study of epileptic psychosis, that schizophrenia relates to left and manic-depressive states relate to right hemisphere epilepsies.

<span class="mw-page-title-main">Region Hovedstadens Psykiatri</span> Hospital in capital region , Denmark

Region Hovedstadens Psykiatri is a psychiatric hospital with centers spread all around the capital region of Denmark, mainly consisting of Copenhagen, northern Zealand, and Bornholm.

<span class="mw-page-title-main">South London and Maudsley NHS Foundation Trust</span> NHS foundation trust based in London, England

South London and Maudsley NHS Foundation Trust, also known as SLaM, is an NHS foundation trust based in London, England, which specialises in mental health. It comprises four psychiatric hospitals, the Ladywell Unit based at University Hospital Lewisham, and over 100 community sites and 300 clinical teams. SLaM forms part of the institutions that make up King's Health Partners, an academic health science centre.

<span class="mw-page-title-main">Michael Shepherd (psychiatrist)</span> Psychiatrist

Michael Shepherd, CBE, FRCP, FRCPsych (Hon), FAPA (Corr), FAPHA was one of the most influential and internationally respected psychiatrists of his time, formerly Professor of Epidemiological Psychiatry, Institute of Psychiatry and Consultant Psychiatrist, The Maudsley Hospital, London and author of a number of influential publications in the field of psychiatry, including the seminal work Psychiatric Illness in General Practice.

<span class="mw-page-title-main">National Psychosis Unit</span> Hospital in England

The National Psychosis Unit is a national treatment centre for patients with schizophrenia and other psychotic disorders, in the United Kingdom. The unit is a tertiary referral centre in the National Health Service. It is located at the Bethlem Royal Hospital, part of the South London and Maudsley NHS Foundation Trust. It is closely affiliated to the Institute of Psychiatry, King's College London, and forms part of the Psychosis Clinical Academic Group of King's Health Partners.

Glyn Lewis is a British professor of psychiatric epidemiology and the current head of the Division of Psychiatry at University College London

Sex differences in schizophrenia are widely reported. Men and women exhibit different rates of incidence and prevalence, age at onset, symptom expression, course of illness, and response to treatment. Reviews of the literature suggest that understanding the implications of sex differences on schizophrenia may help inform individualized treatment and positively affect outcomes.

<span class="mw-page-title-main">Mary Cannon</span> Irish psychiatrist and research scientist

Mary Cannon is an Irish psychiatrist, research scientist, public figure, and former member of the Cannabis Risk Alliance. She has received the Royal Academy of Medicine in Ireland's "Doctors Award" for psychiatry and is among the most highly cited scientists in the world. Cannon is known for her views on cannabis, being described as 'anti-cannabis'. She is best known in the field of psychiatry for her study of the risk factors for mental illness in young people.

Psychiatry is, and has historically been, viewed as controversial by those under its care, as well as sociologists and psychiatrists themselves. There are a variety of reasons cited for this controversy, including the subjectivity of diagnosis, the use of diagnosis and treatment for social and political control including detaining citizens and treating them without consent, the side effects of treatments such as electroconvulsive therapy, antipsychotics and historical procedures like the lobotomy and other forms of psychosurgery or insulin shock therapy, and the history of racism within the profession in the United States.

F. Markus Leweke is a German psychiatrist and psychotherapist. He is a professor and Chair in Youth Depression Studies at the Brain and Mind Centre of the University of Sydney, Australia and a work group leader at the Central Institute of Mental Health in Mannheim, Germany.

<span class="mw-page-title-main">Arsime Demjaha</span> Kosovo-born British psychiatrist and research scientist

Arsime Demjaha is a Kosovo-born British psychiatrist and research scientist who is an Honorary Clinical Lecturer at the Institute of Psychiatry, Psychology and Neuroscience (IOPPN), King's College London. Demjaha is known for her work in neurobiology of treatment resistant schizophrenia and treats patients with severe psychotic disorders at South London and Maudsley NHS Trust.

References

  1. 1 2 "IoP: staff: MURRAY, Sir Robin M." Iop.kcl.ac.uk. 27 January 2011. Retrieved 4 May 2012.
  2. "NPU: staff: Professor Robin Murray". www.national.slam.nhs.uk. 1 February 2015. Retrieved 17 May 2018.
  3. Scientist Rankings in Psychiatry/Psychology
  4. 1 2 Profile in Science Watch and interview with Murray, sciencewatch.com, 8 March 2008; accessed 1 September 2014.
  5. "Cambridge Journals Online – Psychological Medicine". Journals.cambridge.org. Retrieved 4 May 2012.
  6. Robin Murray, A clear danger from cannabis, The Guardian, 29 October 2009 replying to David Nutt The cannabis conundrum, The Guardian , 29 October 2009; accessed 1 September 2014.
  7. Cannabis 'disrupts brain centre'. Scientists have shown how cannabis may trigger psychotic illnesses such as schizophrenia
  8. Cannabis hospital admissions rise. Mental health hospital admissions in England due to cannabis have risen by 85% under Labour, figures show
  9. Parents 'ignorant about cannabis'. Police chiefs are accusing parents of showing ignorance and complacency in the face of widespread cannabis use among teenage children.
  10. Cannabis and our genes
  11. Programme transcript. What follows is a transcript of Panorama's Cannabis:what teenagers need to know. Broadcast Sunday 19 June 2005 on BBC One, bbc.co.uk; accessed 1 September 2014.
  12. "No. 59647". The London Gazette (Supplement). 31 December 2010. p. 1.